Barbados | Imports and Exports | World | Pharmaceutical products | Value (US$) and Value Growth, YoY (%) | 2012 - 2023
The value of exports of commodity group 30 "Pharmaceutical products" from Barbados totalled $ 29 million in 2023. Sales of commodity group 30 from Barbados went up by 17.8% compared to 2022: exports of commodity group 30 "Pharmaceutical products" went up by $ 4.48 million (cumulative exports of commodity group 30 from Barbados amounted $25 million in 2022)
Exports of commodity group 30 "Pharmaceutical products" amounted to 6.23% of total exports from Barbados (cumulative merchandise exports from Barbados totalled $ 475 million in 2023). The share of commodity group 30 in total exports from Barbados increased by 1.17 p.p. compared to 2022 (it was 5.05% in 2022 and cumulative exports from Barbados were equal to $ 497 million).
Where does Barbados export Pharmaceutical products?
Top export destinations of "Pharmaceutical products" from Barbados in 2023:
- Trinidad and Tobago with a share of 14.9% (4.42 million US$)
- Jamaica with a share of 14.8% (4.39 million US$)
- Saint Vincent and the Grenadines with a share of 13.3% (3.97 million US$)
- Antigua and Barbuda with a share of 11.2% (3.32 million US$)
- Saint Lucia with a share of 10% (2.96 million US$)
- Grenada with a share of 8.44% (2.5 million US$)
- The Bahamas with a share of 6.65% (1.97 million US$)
- Saint Kitts and Nevis with a share of 4.58% (1.35 million US$)
- British Virgin Islands with a share of 3.71% (1.1 million US$)
- Dominica with a share of 3.16% (937 thousand US$)
Exports structure of 30 - Pharmaceutical products - from Barbados in 2023 represented by the following main commodity groups:
- 94% (28 million US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 1.88% (558 thousand US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
- 1.64% (487 thousand US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
- 1.08% (323 thousand US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 0.57% (169 thousand US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 0.023% (7.06 thousand US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
The value of imports of commodity group 30 "Pharmaceutical products" to Barbados totalled $ 45 million in 2023. Sales of commodity group 30 to Barbados decreased by 4.37% in value terms compared to 2022. imports of commodity group 30 "Pharmaceutical products" decreased by $ 2.1 million (the value of imports of commodity group 30 to Barbados was equal to $48 million in 2022)
Imports of commodity group 30 "Pharmaceutical products" accounted for 2.14% of total import flow to Barbados (in 2023, total imports to Barbados amounted to $ 2.14 billion). The share of commodity group 30 in total imports to Barbados decreased by 0.089 p.p. compared to 2022 (it was 2.23% in 2022 and cumulative imports to Barbados were equal to $ 2.15 billion).
Where does Barbados import Pharmaceutical products from?
Top trading partners (import of "Pharmaceutical products") of Barbados in 2023:
- Panama with a share of 51% (23 million US$)
- USA with a share of 18% (8.3 million US$)
- India with a share of 5.79% (2.66 million US$)
- United Kingdom with a share of 5.08% (2.33 million US$)
- Canada with a share of 2.46% (1.13 million US$)
- Germany with a share of 1.72% (790 thousand US$)
- Costa Rica with a share of 1.59% (732 thousand US$)
- Jamaica with a share of 1.26% (580 thousand US$)
- Mexico with a share of 1.16% (536 thousand US$)
- Denmark with a share of 1.12% (517 thousand US$)
Imports structure of 30 - Pharmaceutical products - to Barbados in 2023 represented by the following main commodity groups:
- 91% (41 million US$): 3004 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of mixed or unmixed products for therapeutic or prophylactic uses, put up in measured doses (including those in the form of transdermal administration systems) or in forms or packings for retail sale
- 2.6% (1.19 million US$): 3006 - Pharmaceutical goods specified in Note 4 to this Chapter.
- 2.06% (948 thousand US$): 3005 - Wadding, gauze, bandages and similar articles (for example, dressings, adhesive plasters, poultices), impregnated or coated with pharmaceutical substances or put up in forms or packings for retail sale for medical, surgical, dental or veterinary purposes.
- 1.78% (821 thousand US$): 3002 - Human blood; animal blood for therapeutic, prophylactic or diagnostic uses; antisera, other blood fractions, immunological products, modified or obtained by biotechnological processes; vaccines, toxins, cultures of micro-organisms (excluding yeasts) etc
- 1.69% (776 thousand US$): 3003 - Medicaments (excluding goods of heading 30.02, 30.05 or 30.06) consisting of two or more constituents which have been mixed together for therapeutic or prophylactic uses, not put up in measured doses or in forms or packings for retail sale
- 0.504% (231 thousand US$): 3001 - Glands, organs (extracts, secretions thereof) for organo-therapeutic uses, dried, powdered or not; heparin and its salts; other human or animal substances for therapeutic or prophylactic uses n.e.s.
